NorthCrest Asset Manangement’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$668K Buy
+3,744
New +$704K 0.02% 482
2026
Q1
Sell
-9,256
Closed -$1.69M 780
2025
Q4
$1.69M Sell
9,256
-266
-3% -$46.7K 0.04% 281
2025
Q3
$1.64M Buy
9,522
+24
+0.3% +$3.63K 0.04% 264
2025
Q2
$1.32M Sell
9,498
-46
-0.5% -$6.45K 0.04% 269
2025
Q1
$1.4M Sell
9,544
-2,105
-18% -$305K 0.04% 247
2024
Q4
$1.53M Sell
11,649
-221
-2% -$30.9K 0.05% 235
2024
Q3
$1.85M Sell
11,870
-17
-0.1% -$2.74K 0.06% 212
2024
Q2
$1.85M Sell
11,887
-185
-2% -$27.8K 0.06% 206
2024
Q1
$1.64M Sell
12,072
-390
-3% -$51.6K 0.06% 219
2023
Q4
$1.68M Sell
12,462
-263
-2% -$34.2K 0.06% 210
2023
Q3
$1.72M Sell
12,725
-170
-1% -$23.2K 0.07% 200
2023
Q2
$1.85M Sell
12,895
-253
-2% -$37.2K 0.07% 193
2023
Q1
$1.83M Buy
13,148
+716
+6% +$96.3K 0.08% 186
2022
Q4
$1.69M Sell
12,432
-882
-7% -$111K 0.1% 132
2022
Q3
$1.46M Buy
13,314
+392
+3% +$49.7K 0.08% 169
2022
Q2
$1.71M Sell
12,922
-80
-0.6% -$10.5K 0.09% 164
2022
Q1
$1.73M Buy
13,002
+640
+5% +$76.8K 0.08% 143
2021
Q4
$1.44M Buy
+12,362
New +$1.45M 0.08% 186

Other funds holding AZN

NorthCrest Asset Manangement's AZN Position: Q2 2026 in Review

NorthCrest Asset Manangement opened a new position in AstraZeneca (AZN) in Q2 2026: 3,744 shares worth $668K. The stake represents 0.02% of the portfolio and ranks #482 among its holdings. This is a return to the name: NorthCrest Asset Manangement previously reported a position in AZN as recently as Q4 2025.

NorthCrest Asset Manangement first reported a position in AZN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.85M in Q2 2024. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • NorthCrest Asset Manangement held 3,744 shares of AstraZeneca worth $668K as of Q2 2026.
  • AstraZeneca was a new NorthCrest Asset Manangement position in Q2 2026.
  • AstraZeneca made up 0.02% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #482 holding.
  • NorthCrest Asset Manangement first reported a position in AstraZeneca in Q4 2021 and has held it in 18 quarters since.
  • NorthCrest Asset Manangement's AstraZeneca position peaked at $1.85M in Q2 2024.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.